Funding news
TRexBio logo

TRexBio Secures $84 Million in Series B Funding to Advance Revolutionary Therapeutics for Cancer and Inflammatory Diseases

Recently funded · $84.0M Series bBiotechnology

Get the full TRexBio company profile

Access contacts, investors, buying signals & more

Open in Dashboard

TRexBio, a pioneering discovery stage biotechnology company based in South San Francisco, has successfully raised an impressive $84 million in its latest funding round. Specializing in the intersection of computational biology and immunobiology, TRexBio is at the forefront of developing groundbreaking therapeutics aimed at tackling cancer and inflammatory diseases. This new capital will primarily be allocated towards advancing its innovative 'deep biology' discovery engine, which meticulously maps the behavior of T regulatory cells (Tregs) within human tissue as they relate to various disease processes. By integrating advanced computational tools with a keen focus on human biology, TRexBio is capable of identifying and characterizing novel therapeutic targets, paving the way for a robust portfolio of therapies designed to modulate the immune system effectively. The funds will also support the company’s ongoing research and development efforts, enabling it to enhance its pipeline of unique therapies that seek to restore immune homeostasis in affected patients. This funding marks a significant milestone in TRexBio's journey, empowering the team to accelerate its mission of revolutionizing treatment paradigms and ultimately improving patient outcomes in the realms of oncology and inflammatory diseases. As the biotechnology landscape continues to evolve, investments such as these underscore the critical importance of innovation-driven approaches to healthcare—a cornerstone of TRexBio's vision for the future.

Other recently funded companies

View all

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
PhoenixAI logo

PhoenixAI

United States

$80.0M
2
Coram AI logo

Coram AI

United States

$35.0M
3
City Therapeutics logo

City Therapeutics

$99.5M
4
Mygate logo

Mygate

India

$23.6M
5
Nagish logo

Nagish

United States

$85.0M